Influence of gemfibrozil on sulfate transport in human erythrocytes during the oxygenation-deoxygenation cycle

Physiological Research

Volumn 57, Issue 4, 2008, Pages 621-629

  Tellone, E ^a   Ficarra, S ^a   Scatena, R ^b   Giardina, B ^b   Kotyk, A ^c   Russo, A ^a   Colucci, D ^a   Bellocco, E ^a   Lagana', G ^a   Galtieri, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Gemfibrozil; Oxygenation deoxygenation; Sulfate transport

Indexed keywords

ANTILIPEMIC AGENT; BUFFER; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GEMFIBROZIL; HEMOGLOBIN; PHOSPHOPROTEIN PHOSPHATASE; SULFATE; VANADIC ACID;

ADULT; ARTICLE; BLOOD; CALIBRATION; DOSE RESPONSE; DRUG EFFECT; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HUMAN; IN VITRO STUDY; KINETICS; METABOLISM; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSIOLOGY; PROTEIN CONFORMATION;

ADULT; ANTILIPEMIC AGENTS; BUFFERS; CALIBRATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; GEMFIBROZIL; HEMOGLOBINS; HUMANS; INDICATORS AND REAGENTS; KINETICS; MIDDLE AGED; OXYGEN CONSUMPTION; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN CONFORMATION; SULFATES; VANADATES;

EID: 50449100513     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ABRAHAM DJ, PERUTZ MF, PHILLIPS SEV: Physiological and X-ray studies of potential antisickling agents. Proc Natl Acad Sci USA 80: 324-328, 1983.
2. BENNETT V: The membrane skeleton of human erythrocytes and its implications for more complex cells. Annu Rev Biochem 54: 273-304, 1985.
3. BETTATI S, MOZZARELLI A: T state hemoglobin binds oxygen noncooperatively with allosteric effects of protons, inositol hexaphosphate, and chloride. J Biol Chem 272: 32050-32055, 1997.
4. BROWN MS, GOLDSTEIN JL: Atherosclerosis. Scavenging for receptors. Nature 343: 508-509, 1990.
5. BRUNATI AM, BORDIN L, CLARI G, JAMES P, QUADRONI M, BARITONO E, PINNA LA, DONELLA-DEANA A: Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood 96: 1550-1557, 2000.
6. CAMPANELLA ME, CHU H, LOW PS: Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc Natl Acad Sci USA 102: 2402-2407, 2005.
7. CHANCE DS, MCINTOSH MK: Hypolipidemic agent alter hepatic mitochondrial respiration in vitro. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 111: 317-323, 1995.
8. CHETRITE G, CASSOLY R: Affinity of hemoglobin for the cytoplasmic fragment of human erythrocyte membrane band 3. Equilibrium measurements at physiological pH using matrix-bound proteins: the effects of ionic strength, deoxygenation and of 2,3-diphosphoglycerate. J Mol Biol 185: 639-644, 1985.
9. CHU H, LOW PS: Mapping of glycolytic enzyme-binding sites on human erythrocyte band 3. Biochem J 400: 143-151, 2006.
10. COLETTA M, ANGELETTI M, ASCENZI P, BERTOLLINI A, DELLA LONGA S, DE SANCTIS G, PRIORI AM, SANTUCCI R, AMICONI G: Coupling of the oxygen-linked interaction energy for inositol hexakisphosphate and bezafibrate binding to human HbA0. J Biol Chem 274: 6865-6874, 1999.
11. FRICK MH, ELO O, HAAPA K, HEININEN OP, HEINSALMI P, HELO P, HUTTUNEN JK, KAITANIENI P, KOSKINENP, MANNINEN V: Helsinki Heart Study: primary-prevention trial with gemfibrozil in middleaged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317: 1237-1234, 1987.
12. GALTIERI A, TELLONE E, ROMANO L, MISITI F, BELLOCCO E, FICARRA S, RUSSO A, DI ROSA D, CASTAGNOLA M, GIARDINA B, MESSANA I: Band-3 protein function in human erythrocytes: effect of oxygenation-deoxygenation. Biochim Biophys Acta 1564: 214-218, 2002.
13. GIARDINA B, MESSANA I, SCATENA R, CASTAGNOLA M: The multiple functions of hemoglobin. Crit Rev Biochem Mol Biol 30: 165-196, 1995.
14. GOODALL HB, REID AH, FINDLAY DJ, HIND C, KAY J AND COGHILL G: Irregular distortion of the erythrocytes (acanthocytes, spur cells) in senile dementia. Dis Mark 12: 23-41, 1994.
15. HAN BG, NUNOMUR WA, TAKAKUWA Y, MOHANDAS N, JAP BK: Protein 4.1 core domain structure and insights into regulation of cytoskeletal organization. Nat Struct Biol 7: 871-875, 2000.
16. HARRIS SJ, WINZOR DJ: Interaction of glycolytic enzymes with erythrocyte membranes. Biochim Biophys Acta 1038: 306-314, 1990.
17. HARRISON ML, ISAACSON CC, BURG DL, GEAHLEN RL, LOW PS: Phosphorylation of human erythrocyte band 3 endogenus p72syk. J Biol Chem 269: 955-959, 1994.
18. HYDE RM, LIVINGSTONE DJ, PATTERSON RA, BATCHELOR JF, KING WR: Modification of the haemoglobin oxygen dissociation curve in whole blood by a compound with dual action. Lancet 2: 15-16, 1984.
19. IMAI K, TSUNESHIGE A, YONETANI T: Description of hemoglobin oxygenation under universal solution conditions by a global allostery model with a single adjustable parameter. Biophys Chem 98: 79-91, 2002.
20. JAY DG: Characterization of the chicken erythrocyte anion exchange protein. J Biol Chem 258: 9431-9436, 1983.
21. JENSEN FB, JAKOBSEN MH, WEBER RE: Interaction between haemoglobin and synthetic peptides of the Nterminal fragment of trout band 3 (AE1) protein. J Exp Biol 201: 2685-2690, 1998.
22. JIANG W, DING Y, SU Y, JIANG M, HU X, ZHANG Z: Interaction of glucose transporter 1 with anion exchanger 1 in vitro. Biochem Biophys Res Comm 339: 1255-1261, 2006.
23. KLIMAN HJ, STECK TL: Association of glyceraldehyde-3-phosphate dehydrogenase with the human red cell membrane. A kinetic analysis. J Biol Chem 255: 6314-6321, 1980.
24. KORSGREN C, COHEN CM: Purification and properties of human erythrocyte band 4.2. Association with the cytoplasmic domain of band 3. J Biol Chem 261: 5536-5543, 1986.
25. LABERGE M, KOVESI I, YONETANI T, FIDY J: R-state hemoglobin bound to heterotropic effectors: model of the DPG, IHP, and RSR 13 binding sites. FEBS Lett 579: 627-635, 2005.
26. LABOTKA RJ: Measurement of intracellular pH and deoxyhemoglobin concentration in deoxygenated erythrocytes by phosphorus-31 nuclear magnetic resonance. Biochemistry 23: 5549-5555, 1984.
27. LALEZARI I, LALEZARI P, POYART C, MARDEN M, KISTER J, BOHN B, FERMI G, PERUTZ MF: New effectors of human hemoglobin: structure and function. Biochemistry 29: 1515-1523, 1990.
28. LOW PS: Structure and function of the cytoplasmic domain of band 3: center of erythrocyte membrane-peripheral protein interactions. Biochim Biophys Acta 864: 145-167, 1986.
29. LOW PS, WILLARDSON BM, MOHANDAS N, ROSSI M, SHOHET S: Contribution of the band 3-ankyrin interaction to erythrocyte membrane mechanical stability. Blood 77: 1581-1586, 1991.
30. MANNINEN V, ELO MO, FRICK MH, HAAPA K, HEINONEN OP, HEINSALMI P, HELO P, HUTTUNEN JK, KAITANIEMI P, KOSKINEN P: Lipid alterations and decline in the Helsinki Heart Study. JAMA 260: 641-651, 1988.
31. MARDEN MC, KISTER J, BOHN B, POYART C: T-state hemoglobin with four ligands bound. Biochemistry 27: 1659-1664, 1988.
32. MESSANA I, ORLANDO M, CASSIANO L, PENNACCHIETTI L, ZUPPI C, CASTAGNOLA M, GIARDINA B: Human erythrocyte metabolism is modulated by the O2-linked transition of hemoglobin. FEBS Lett 390: 25-28, 1996.
33. MURTHY SN, LIU T, KAUL RK, KOHLER H, STECK TL: The aldolase-binding site of the human erythrocyte membrane is at the NH2 terminus of band 3. J Biol Chem 256: 11203-11208, 1981.
34. NOBLE RW, DE YOUNG A, VITALE S, CERDONIO M, DI IORIO EE: Spin equilibria in human methemoglobin: effects of bezafibrate and inositol hexaphosphate as measured by susceptometry and visible spectroscopy. Biochemistry 28: 5288-5292, 1989.
35. PERUTZ MF, POYART C: Bezafibrate lowers oxygen affinity of hemoglobin. Lancet 2: 881-882, 1983.
36. PERUTZ MF, FERMI G, ABRAHAM D J, POYART C, BURSAUX E: Hemoglobin as a receptor of drugs and peptides: X-ray studies of the stereochemistry of binding. J Am Chem Soc 108: 1064-1078, 1986.
37. POYART C, MARDEN MC, KISTER J: Bezafibrate derivatives as potent effectors of hemoglobin. Methods Enzymol 232: 496-513, 1994.
38. ROMANO L, PERITORE D, SIMONE E, SIDOTI A, TRISCHITTA F, ROMANO P: Chloride-sulphate exchange chemically measured in human erythrocyte ghosts. Cell Mol Biol 44: 351-355, 1998.
39. RUSSO A, TELLONE E, FICARRA S, GIARDINA B, BELLOCCO E, LAGANA G, LEUZZI U, KOTYK A, GALTIERI A: Band 3 protein function in teleost fish erythrocytes: effect of oxygenation-deoxygenation. Physiol Res 57: 49-54, 2008.
40. SAFO MK, BOYIRI T, BURNETT JC, DANSO-DANQUAH R, MOURE CM, JOSHI GS, ABRAHAM DJ: X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites. Acta Crystallogr D Biol Crystallogr 58: 634-644, 2002.
41. SALHANY JM: Erythocyte Band 3 Protein. CRC Press, Boca Raton, 1990.
42. SCATENA R, NOCCA G, MESSANA I, DE SOLE P, BARONI S, ZUPPI C, CASTAGNOLA M, GIARDINA B: Effects of gemfibrozil on the oxygen transport properties of erythrocytes J Clin Pharmacol 39: 25-30, 1995.
43. SHIBAYAMA N, MIURA S, TAME JRH, YONETANI T, PARK SY: Crystal structure of horse carbonmonoxyhemoglobin-bezafibrate complex at 1.55-A resolution. J Biol Chem 277: 38791-38796, 2002.
44. TSUNESHIGE A, PARK S, YONETANI T: Heterotropic effectors control the hemoglobin function by interacting with its T and R states - a new view on the principle of allostery. Biophys Chem 98: 49-63, 2002.
45. TSUNESHIGE A, KANAORI K, SAMUNI U, DANSTKER D, FRIEDMAN JM, NEYA S, GIANGIACOMO L, YONETANI T: Semihemoglobins: high oxygen affinity dimeric forms of human hemoglobin respond efficiently to allosteric effectors without forming tetramers. J Biol Chem 279: 48959-48967, 2004.
46. WALDER JA, CHATTERJEE R, STECK TL, LOW PS, MUSSO GF, KAISER ET, ROGERS PH, ARNONE A: The interaction of hemoglobin with the cytoplasmic domain of band 3 of the human erythrocyte membrane. J Biol Chem 259: 10238-10246, 1984.
47. WEBER R E, VOELTER W, FAGO A, ECHNER H, CAMPANELLA E, LOW PS: Modulation of red cell glycolysis: interactions between vertebrate hemoglobins and cytoplasmic domains of band 3 red cell membrane proteins. Am J Physiol 287: R454-R464, 2004.
48. 2 affinity, cooperativity, and Bohr effect by heterotropic allosteric effectors. J Biol Chem 277: 34508-34520, 2002.
49. ZIJLSTRA WG, BUURSMA A, MEEUWSEN-VAN DER ROEST WP: Absorption spectra of human fetal and adult oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin. Clin Chem 37: 1633-1638, 1991.
50. ZIPSER Y, KOSOVER NS: Phosphotyrosine phosphatase associated with band 3 protein in human erythrocyte membrane. Biochem J 314: 881-887, 1996.